Literature DB >> 25060254

Sickle cell disease in the emergency department.

Paris B Lovett1, Harsh P Sule2, Bernard L Lopez1.   

Abstract

Acute painful episodes are the most common reason for emergency department visits among patients with sickle cell disease (SCD). Early and aggressive pain management is a priority. Emergency providers (EPs) must also diagnose other emergent diagnoses in patients with SCD and differentiate them from vaso-occlusive crisis. EPs should be aware of cognitive biases that may misdirect the diagnostic process. Administration of intravenous fluids should be used judiciously. Blood transfusion may be considered. Coordination of care with hematology is an important part of the effective emergency department and long-term management of patients with SCD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute chest syndrome; Emergency department; Sickle cell disease; Vaso-occlusive crisis

Mesh:

Year:  2014        PMID: 25060254     DOI: 10.1016/j.emc.2014.04.011

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  4 in total

1.  Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange.

Authors:  Sophie Van Aelst; Helena Claerhout; Elke Nackers; Koen Desmet; Davy Kieffer
Journal:  J Clin Lab Anal       Date:  2018-04-18       Impact factor: 2.352

2.  Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.

Authors:  Jéssica V G F Batista; Diego A Pereira-Martins; Diego A Falcão; Igor F Domingos; Gabriela S Arcanjo; Betânia L Hatzlhofer; Isabel Weinhäuser; Thais H C Batista; Pablo R G Cardoso; Ana C Dos Anjos; Manuela F Hazin; Maira G R Pitta; Fernando F Costa; Aderson S Araujo; Antonio R Lucena-Araujo; Marcos A Bezerra
Journal:  Ann Hematol       Date:  2021-06-14       Impact factor: 3.673

3.  Evidence-Based Practice Standard Care for Acute Pain Management in Adults With Sickle Cell Disease in an Urgent Care Center.

Authors:  Sunghee Kim; Ron Brathwaite; Ook Kim
Journal:  Qual Manag Health Care       Date:  2017 Apr/Jun       Impact factor: 0.926

4.  Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease.

Authors:  Emanuel Almeida Moreira de Oliveira; Kenia de Assis Boy; Ana Paula Pinho Santos; Carla da Silva Machado; Cibele Velloso-Rodrigues; Pâmela Souza Almeida Silva Gerheim; Leonardo Meneghin Mendonça
Journal:  Einstein (Sao Paulo)       Date:  2019-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.